Thursday, July 6, 2017

Konica-Minolta Buys Ambry Genetics for $800M

Konica-Minolta, with financing from the Innovation Network Corporation of Japan, buys Orange County's Ambry Genetics for $800M.

News at:
  • MedcityNews here.
  • Reuters here.
  • New York Times here.
  • Genomeweb (subscription) here.
According to a 2015 CMS provider database, Ambry had $38M in Medicare Part B payments -- although because of MolDx coding rules, $31M fell under unlisted codes, typically used by MolDX when more than 2 genetic tests are used together. (Click to enlarge.)

Ambry has offered an anonymized genetic database called Ambryshare (here).  Other companies offered anonymized research-ready databases include GenomeDx (here) and Foundation Medicine (here).  Genomic datasharing has been strongly advocated by the American College of Medical Genetics (ACMG; here.)